Listed

Dolby Laboratories, Inc.: Form 10-Q for the period ended Jun 27, 2014

Filed with the SEC on Jul 30, 2014 and accepted by EDGAR at Jul 30, 2014, 20:41 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-06-27. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2014-03-29 to 2014-06-27$223.3mus-gaap:Revenues
Revenue9 months2013-09-28 to 2014-06-27$733.2mus-gaap:Revenues
Cost of revenue3 months2014-03-29 to 2014-06-27$18.9mus-gaap:CostOfRevenue
Cost of revenue9 months2013-09-28 to 2014-06-27$57.8mus-gaap:CostOfRevenue
Gross profit3 months2014-03-29 to 2014-06-27$204.5mus-gaap:GrossProfit
Gross profit9 months2013-09-28 to 2014-06-27$675.5mus-gaap:GrossProfit
Research and development3 months2014-03-29 to 2014-06-27$46.8mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2013-09-28 to 2014-06-27$136.0mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2014-03-29 to 2014-06-27$50.6mus-gaap:OperatingIncomeLoss
Operating income9 months2013-09-28 to 2014-06-27$215.4mus-gaap:OperatingIncomeLoss
Interest expense3 months2014-03-29 to 2014-06-27$251.0kus-gaap:InterestExpense
Interest expense9 months2013-09-28 to 2014-06-27$456.0kus-gaap:InterestExpense
Income tax3 months2014-03-29 to 2014-06-27$11.3mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2013-09-28 to 2014-06-27$53.1mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2014-03-29 to 2014-06-27$39.8mus-gaap:NetIncomeLoss
Net income9 months2013-09-28 to 2014-06-27$160.2mus-gaap:NetIncomeLoss
Diluted EPS3 months2014-03-29 to 2014-06-27$0.38us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2013-09-28 to 2014-06-27$1.55us-gaap:EarningsPerShareDiluted
Basic EPS3 months2014-03-29 to 2014-06-27$0.39us-gaap:EarningsPerShareBasic
Basic EPS9 months2013-09-28 to 2014-06-27$1.57us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2014-03-29 to 2014-06-27103,942,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2013-09-28 to 2014-06-27103,605,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2013-09-28 to 2014-06-27$272.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2013-09-28 to 2014-06-27$37.1mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid9 months2013-09-28 to 2014-06-27$0us-gaap:PaymentsOfDividends
Share repurchases3 months2014-03-29 to 2014-06-27$29.3mus-gaap:PaymentsForRepurchaseOfCommonStock
Share repurchases9 months2013-09-28 to 2014-06-27$41.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2014-06-27$590.1mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-06-27$987.0mus-gaap:AssetsCurrent
Total assetsAt period end2014-06-27$1.94bnus-gaap:Assets
Current liabilitiesAt period end2014-06-27$185.2mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2014-06-27$252.6mus-gaap:Liabilities
Shareholders' equityAt period end2014-06-27$1.66bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001445305-14-003111. Last ingested by Listed: Nov 14, 2026, 23:59 ET. Listed shows no prices and gives no investment advice.